Skip to main content
TipRanks
Go Ultimate75% OFF

MiMedx Group (MDXG) Stock Statistics & Valuation Metrics

517 Followers

Total Valuation

MiMedx Group has a market cap or net worth of $464.04M. The enterprise value is $558.94M.

Market Cap
$464.04M
Enterprise Value
$558.94M

Share Statistics

MiMedx Group has 145,925,600 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
145,925,600
Owned by Insiders
2.62%
Owned by Institutions
72.50%

Financial Efficiency

MiMedx Group’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 16.66%.

Return on Equity (ROE)
0.19
Return on Assets (ROA)
0.14
Return on Invested Capital (ROIC)
16.66%
Return on Capital Employed (ROCE)
0.23
Revenue Per Employee
518.11K
Profits Per Employee
60.12K
Employee Count
808
Asset Turnover
1.22
Inventory Turnover
2.88

Valuation Ratios

The current PE Ratio of MiMedx Group is -24.46. MiMedx Group’s PEG ratio is 0.17.

PE Ratio
-24.46
PS Ratio
1.53
PB Ratio
2.20
Price to FCF
22.79
Price to Operating Cash Flow
22.37
PEG Ratio
0.17

Income Statement

In the last 12 months, MiMedx Group had revenue of 418.63M and earned 48.58M in profits. Earnings per share was 0.33.

Revenue
418.63M
Gross Profit
345.62M
Operating Income
63.89M
Pretax Income
66.26M
Net Income
48.58M
EBITDA
82.93M
Earnings Per Share (EPS)
0.33

Cash Flow

In the last 12 months, operating cash flow was 20.74M and capital expenditures -377,000, giving a free cash flow of 20.36M billion.

Operating Cash Flow
20.74M
Free Cash Flow
20.36M
Free Cash Flow per Share
0.14

Dividends & Yields

MiMedx Group pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
4.36%
Earnings Yield
-4.11%

Stock Price Statistics

Beta
0.59
52-Week Price Change
-52.68%
50-Day Moving Average
4.23
200-Day Moving Average
4.14
Relative Strength Index (RSI)
25.22
Average Volume (3m)
1.36M

Important Dates

MiMedx Group upcoming earnings date is Mar 03, 2027, TBA (Not Confirmed).

Last Earnings Date
Oct 28, 2026
Next Earnings Date
Mar 03, 2027
Ex-Dividend Date
―

Financial Position

MiMedx Group as a current ratio of 4.32, with Debt / Equity ratio of 8.78%

Current Ratio
4.32
Quick Ratio
3.92
Debt to Market Cap
0.02
Net Debt to EBITDA
-1.73
Interest Coverage Ratio
35.83

Taxes

In the past 12 months, MiMedx Group has paid 17.68M in taxes.

Income Tax
17.68M
Effective Tax Rate
0.27

Enterprise Valuation

MiMedx Group EV to EBITDA ratio is -23.83, with an EV/FCF ratio of 17.00.

EV to Sales
1.14
EV to EBITDA
-23.83
EV to Free Cash Flow
17.00
EV to Operating Cash Flow
16.69

Balance Sheet

MiMedx Group has $120.79M in cash and marketable securities with $0.00 in debt, giving a net cash position of $120.79M billion.

Cash & Marketable Securities
$120.79M
Total Debt
$0.00
Net Cash
$120.79M
Net Cash Per Share
$0.83
Tangible Book Value Per Share
$1.24

Margins

Gross margin is 77.29%, with operating margin of -8.28%, and net profit margin of -6.32%.

Gross Margin
77.29%
Operating Margin
-8.28%
Pretax Margin
-7.37%
Net Profit Margin
-6.32%
EBITDA Margin
-4.78%
EBIT Margin
-7.36%

Analyst Forecast

The average price target for MiMedx Group is $7.25, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target
$7.25
Price Target Upside
127.99% Upside
Analyst Consensus
Strong Buy
Analyst Count
4
Revenue Growth Forecast
-22.80%
EPS Growth Forecast
-147.20%

Scores

Smart Score
7
AI Score
53